Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.

Piermarocchi S, Saviano S, Parisi V, Tedeschi M, Panozzo G, Scarpa G, Boschi G, Lo Giudice G; Carmis Study Group.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):216-25. doi: 10.5301/ejo.5000069.

PMID:
22009916
2.

Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.

Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S; CARMIS Study Group.

Ophthalmology. 2008 Feb;115(2):324-333.e2. Epub 2007 Aug 22.

PMID:
17716735
3.

Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.

Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, Xu XR, Zou ZY, Dong PC, Xiao X, Wang X, Sun TT, Dou HL, Lin XM.

Ophthalmology. 2012 Nov;119(11):2290-7. doi: 10.1016/j.ophtha.2012.06.014. Epub 2012 Aug 1.

PMID:
22858124
4.

Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.

Dawczynski J, Jentsch S, Schweitzer D, Hammer M, Lang GE, Strobel J.

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2711-23. doi: 10.1007/s00417-013-2376-6. Epub 2013 May 22.

PMID:
23695657
5.

Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.

Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J.

Ophthalmic Epidemiol. 2014 Apr;21(2):111-23. doi: 10.3109/09286586.2014.888085.

6.

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.

Akuffo KO, Beatty S, Peto T, Stack J, Stringham J, Kelly D, Leung I, Corcoran L, Nolan JM.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5347-5360. doi: 10.1167/iovs.16-21192.

PMID:
29053808
8.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

9.

Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.

Wolf-Schnurrbusch UE, Zinkernagel MS, Munk MR, Ebneter A, Wolf S.

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8069-74. doi: 10.1167/iovs.15-17586.

PMID:
26720458
10.

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.

Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C.

Optometry. 2011 Nov;82(11):667-680.e6. doi: 10.1016/j.optm.2011.08.008.

PMID:
22027699
11.

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.

Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR.

Ophthalmology. 2013 Mar;120(3):600-6. doi: 10.1016/j.ophtha.2012.08.040. Epub 2012 Dec 6.

PMID:
23218821
12.

Nutritional supplements in age-related macular degeneration.

Schmidl D, Garhöfer G, Schmetterer L.

Acta Ophthalmol. 2015 Mar;93(2):105-21. doi: 10.1111/aos.12650. Epub 2015 Jan 13. Review.

13.

Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.

Wu J, Cho E, Willett WC, Sastry SM, Schaumberg DA.

JAMA Ophthalmol. 2015 Dec;133(12):1415-24. doi: 10.1001/jamaophthalmol.2015.3590.

14.

Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.

Akuffo KO, Nolan JM, Howard AN, Moran R, Stack J, Klein R, Klein BE, Meuer SM, Sabour-Pickett S, Thurnham DI, Beatty S.

Eye (Lond). 2015 Jul;29(7):902-12. doi: 10.1038/eye.2015.64. Epub 2015 May 15.

15.

Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.

Chew EY, Clemons TE, Agrón E, Launer LJ, Grodstein F, Bernstein PS; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

JAMA. 2015 Aug 25;314(8):791-801. doi: 10.1001/jama.2015.9677.

16.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Age-Related Eye Disease Study 2 Research Group.

JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997. Erratum in: JAMA. 2013 Jul 10;310(2):208.

PMID:
23644932
17.

[The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].

Zeimer M, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D.

Ophthalmologe. 2009 Jan;106(1):29-36. doi: 10.1007/s00347-008-1773-4. German.

PMID:
18551295
18.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.

JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376.

19.

Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.

Liu R, Wang T, Zhang B, Qin L, Wu C, Li Q, Ma L.

Invest Ophthalmol Vis Sci. 2014 Dec 16;56(1):252-8. doi: 10.1167/iovs.14-15553. Review.

PMID:
25515572
20.

Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.

Age-Related Eye Disease Study 2 Research Group, Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY.

Ophthalmology. 2014 Jun;121(6):1229-36. doi: 10.1016/j.ophtha.2013.12.035. Epub 2014 Mar 7.

Supplemental Content

Support Center